P642: IMPACT OF TYPE 2 DIABETES ON SURVIVAL AND TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

• E. Curovic Rotbain,
• K. Rostgaard,
• M. A. Andersen,
• N. Vainer,
• C. Da Cunha-Bang,
• H. Hjalgrim,
• H. Frederiksen,
• S. Slager,
• C. Utoft Niemann

Affiliations

E. Curovic Rotbain

1 Department of Hematology, Rigshospitalet

K. Rostgaard

2 Hematology Group, Danish Cancer Society Research Center, Copenhagen

M. A. Andersen

1 Department of Hematology, Rigshospitalet

N. Vainer

1 Department of Hematology, Rigshospitalet

C. Da Cunha-Bang

1 Department of Hematology, Rigshospitalet

H. Hjalgrim

1 Department of Hematology, Rigshospitalet

H. Frederiksen

3 Department of Hematology, Odense University Hospital, Odense

S. Slager

9 Department of Health Sciences Research, Mayo Clinic, Rochester, United States of America

C. Utoft Niemann

1 Department of Hematology, Rigshospitalet